Position in ALEC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,750,507
+$1,128,644 QoQ
Shares Held
1,279,306
+23.1% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,513,200,662 across 316 Biotechnology names. ALEC ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in ALEC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,750,507 | 1,279,306 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,621,863 | 1,039,656 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $909,249 | 307,179 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $310,994 | 222,139 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $263,742 | 214,425 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $771,099 | 407,989 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,223,352 | 262,522 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,371,706 | 302,138 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,195,066 | 364,629 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,536,525 | 192,547 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $663,752 | 102,431 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,729,173 | 287,716 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,267,427 | 366,305 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,311,995 | 250,487 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,643,436 | 279,433 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,654,056 | 261,226 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,001,613 | 280,815 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,183,866 | 347,887 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,769,890 | 340,486 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $945,625 | 62,500 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,925,007 | 467,490 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,470,173 | 182,904 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $948,381 | 39,303 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||